Study Indicates Metagenomic Next-Generation Sequencing Quickly Identifies Clinically Significant Pathogens In Patients With Lower Respiratory Tract Infections

Infectious Disease Advisor (4/22, Nye) reports, “Metagenomic next-generation sequencing (mNGS) rapidly detects pathogens of clinical significance among patients with lower respiratory tract infection (LRTI), demonstrating its supplementary value in diagnosis and treatment decisions in clinical practice.” These research findings were published in Infection. Infectious Disease Advisor adds, “To assess whether mNGS has clinical utility in the treatment and diagnosis of LRTIs, researchers conducted a retrospective study using data captured from patients (N=201) with suspected LRTIs at Jinling Hospital in China between 2021 and 2022.”